Fractalkine Mediates Natural Killer-Dependent Antitumor Responses in Vivo

Cancer Research

Volumn 63, Issue 21, 2003, Pages 7468-7474

  Lavergne, Elise ^a   Combadière, Behazine ^a   Bonduelle, Olivia ^a   Iga, Mutsunori ^a   Gao, Ji Liang ^b   Maho, Maud ^a   Boissonnas, Alexandre ^a   Murphy, Philip M ^b   Debré, Patrice ^a   Combadière, Christophe ^a,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC ANTIBODY; FRACTALKINE; GAMMA INTERFERON; PERFORIN; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL ACTIVITY; CELL FUNCTION; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG ACTIVITY; EFFECTOR CELL; FEMALE; GENETIC TRANSFECTION; IMMUNE RESPONSE; LYMPHOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; B-LYMPHOCYTES; CHEMOKINES, CX3C; DNA; FEMALE; HUMANS; IMMUNOGLOBULIN G; KILLER CELLS, NATURAL; LYMPHOMA; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, NUDE; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TRANSFECTION;

EID: 0242442490     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76: 301-314, 1994.
2. Campbell, J. J., and Butcher, E. C. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol., 12: 336-341, 2000.
3. Rossi, D., and Zlotnik, A. The biology of chemokines and their receptors. Annu. Rev. Immunol., 18: 217-242, 2000.
4. Homey, B., Muller, A., and Zlotnik, A. Chemokines: agents for the immunotherapy of cancer? Nat. Rev. Immunol., 2: 175-184, 2002.
5. Zlotnik, A., and Yoshie, O. Chemokines: a new classification system and their role in immunity. Immunity., 12: 121-127, 2000.
6. Wang, J. M., Deng, X., Gong, W., and Su, S. Chemokines and their role in tumor growth and metastasis. J. Immunol. Methods., 220: 1-17, 1998.
7. Balkwill, F. and Mantovani, A. Inflammation and cancer: back to Virchow? Lancet., 357: 539-545, 2001.
8. Vicari, A. P., and Caux, C. Chemokines in cancer Cytokine Growth. Factor. Rev., 13: 143-154, 2002.
9. Muller, A. Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E., and Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis. Nature (Lond), 410: 50-56, 2001.
10. Menten, P., Saccani, A., Dillen, C., Wuyts, A., Struyf, S. Proost, P., Mantovani, A. Wang, J. M., and Van Damme J. Role of the autocrine chemokines MIP-1α and MIP-1β in the metastatic behavior of murine T cell lymphoma. J. Leukocyte Biol., 72: 780-789, 2002.
11. Norgauer, J., Metzner, B., and Schraufstatter, I. Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells. J. Immunol., 156: 1132-1137, 1996.
12. Owen, J. D., Strieter, R., Burdick, M., Haghnegahdar, H., Nanney, L. Shattuck-Brandt, R., and Richmond, A. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine β and γ proteins. Int. J. Cancer. 73: 94-103, 1997.
13. Moore, B. B. Arenberg, D. A., Stoy, K., Morgan, T., Addison, C. L., Morris, S. B. Glass, M., Wilke, C., Xue, Y. Y., Sitterding S., Kunkel, S. L., Burdick, M. D. and Strieter, R. M. Distinct CXC chemokines mediate tumor/genicity of prostate cancer cells. Am. J. Pathol., 154: 1503-1512, 1999.
14. Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves D. R., Zlotnik, A., and Schall, T. J. A new class of membrane-bound chemokine with a CX3C motif. Nature (Lond), 385: 640-644, 1997.
15. Matloubian, M., David, A., Engel, S., Ryan, J. E., and Cyster, J. G. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol., 1: 298-304, 2000.
16. Pan, Y., Lloyd, C., Zhou, H., Dolich, S. Deeds, J., Gonzalo, J. A., Vath J., Gosselin, M., Ma, J., Dussault, B., Woolf, E., Alperin, G., Culpepper, J., Gutierrez-Ramos, J. C., and Gearing D. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature (Lond), 387: 611-617, 1997.
17. Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H. Schall, T. J., and Yoshie, O., Identification and molecular characterization of fractalkine receptor CX3CR1 which mediates both leukocyte migration and adhesion. Cell, 91: 521-530, 1997.
18. Fong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T., and Patel, D. D. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med., 188: 1413-1419, 1998.
19. Combadiere, C., Salzwedel, K., Smith, E. D., Tiffany, H. L., Berger, E. A., and Murphy, P. M. Identification of CX3CR1 A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. J. Biol. Chem. 273: 23799-23804, 1998.
20. Nishimura, M., Umehara, H., Nakayama, T., Yoneda, O., Hieshima, K., Kakizaki, M., Dohmae, N., Yoshie, O., and Imai, T. Dual functions of fractalkine/CX3C ligand 1 in trafficking of pefforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J. Immunol., 168: 6173-6180, 2002.
21. Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., and Littman, D. R. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol., 20: 4106-4114, 2000.
22. Biragyn, A., Tani, K., Grimm, M. C., Weeks, S., and Kwak, L. W. Genetic fusion of chemokines to a self tumor antigen induces protective T-cell dependent antitumor immunity. Nat. Biotechnol., 17: 253-258, 1999.
23. Biragyn, A., Surenhu, M., Yang, D., Ruffini, P. A., Haines, B. A., Klyushnenkova, E., Oppenheim, J. J., and Kwak, L. W. Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J. Immunol., 167: 6644-6653, 2001.
24. Combadiere, C., Potteaux, S., Gao, J. L., Esposito, B., Casanova, S., Lee, E. J., Debre, P., Tedgui, A., Murphy, P. M., and Mallat, Z. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice Circulation 107: 1009-1016, 2003.
25. Moatti, D., Faure, S., Fumeron, F., Amara, M., Seknadji, P., McDermott, D. H., Debre, P., Aumont, M. C., Murphy, P. M., de Prost, D. and Combadiere, C. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood, 97: 1925-1928, 2001.
26. Barouch, D. H., Santra, S., Steenbeke, T. D., Zheng, X. X., Perry, H. C., Davies, M. E., Freed, D. C., Craiu, A., Strom, T. B., Shiver, J. W., and Letvin, N. L. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J. Immunol., 161: 1875-1882, 1998.
27. Fujiwara, H., and Hamaoka, T. Coordination of chemokine and adhesion systems in intratumoral T cell migration responsible for the induction of tumor regression. Int. Immunopharmacol., 1: 613-623, 2001.
28. Combadiere, B., Faure, S., Autran, B., Debre, P., and Combadiere, C. The chemokine receptor CX3CR1 controls homing and anti-viral potencies of CD8 effector-memory T lymphocytes in HIV-infected patients. AIDS 17: 1279-1290, 2003.
29. Yoneda, O., Imai, T., Goda, S., Inoue, H., Yamauchi, A., Okazaki, T., Imai, H., Yoshie, O., Bloom, E. T., Domae, N., and Umehara, H. Fractalkine-mediated endothelial cell injury by NK cells. J. Immunol., 164: 4055-4062, 2000.
30. Volin, M. V., Woods, J. M., Amin, M. A., Connors, M. A., Harlow, L. A., and Koch, A. E. Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am. J. Pathol., 159, 1521-1530, 2001.
31. Krasagakis, K., Garbe, C., Zouboulis, C. C., and Orfanos, C. E., Growth control of melanoma cells and melanocytes by cytokines. Recent Res. Cancer Res., 139: 169-182, 1995.
32. Farrar, J. D., Katz, K. H., Windsor, J., Thrush, G., Scheuermann, R. H., Uhr, J. W., and Street, N. E. Cancer dormancy VII A regulatory role for CD8+ T cells and IFN-γ in establishing and maintaining the tumor-dormant state. J. Immunol., 162: 2842-2849, 1999.
33. Boehm, U., Klamp, T., Groot, M., and Howard, J. C. Cellular responses to interferon-γ. Annu. Rev. Immunol., 15: 749-795, 1997.
34. Wong, L. H., Hatzinisiriou, I., Devenish, R. J., and Ralph, S. J., IFN-γ priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type 1 IFNs. J. Immunol., 160: 5475-5484, 1998.
35. Dobrzanski, M. J., Reome, J. B., and Dutton, R. W. Immunopotentiating role of IFN-γ in early and late stages of type 1 CD8 effector cell-mediated tumor rejection. Clin. Immunol., 98: 70-84, 2001.
36. Dobrzanski, M. J., Reome, J. B., and Dutton, R. W. Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases. J. Immunol., 162: 6671-6680, 1999.
37. Helmich, B. K., and Dutton, R. W. The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors. J. Immunol., 166: 6500-6508, 2001.
38. Luster, A. D., Unkeless, J. C., and Ravetch, J. V. γ-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature (Lond), 315: 672-676, 1985.
39. Fujimoto, K., Imaizumi, T., Yoshida, H., Takanashi, S., Okumura, K., and Satoh, K. Interferon-γ stimulates fractalkine expression in human bronchial epithelial cells and regulates mononuclear cell adherence. Am. J. Respir. Cell Mol. Biol., 25: 233-238, 2001.
40. Ludwig, A., Berkhout, T., Moores, K., Groot, P., and Chapman, G., Fractalkine is expressed by smooth muscle cells in response to IFN-γ and TNF-α and is modulated by metalloproteinase activity. J. Immunol., 168: 604-612, 2002.
41. Fraticelli, P., Sironi, M., Bianchi, G., D'Ambrosio, D., Albanesi, C., Stoppacciaro, A., Chieppa, M., Allavena, P., Ruco, L., Girolomoni, G., Sinigaglia, F., Vecchi, A., and Mantovani, A. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J. Clin. Invest., 107: 1173-1181, 2001.
42. Zheng, X. X., Steele, A. W., Nickerson, P. W., Steurer, W., Steiger, J., and Strom, T. B. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J. Immunol., 154: 5590-5600, 1995.